Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4143526

CN(C)CCN1CCn2c(c([C@H]3CCCC[C@@H]3F)c3ccc(-c4nnn[nH]4)cc32)-c2ccccc2C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.33
MMP12 P39900 1/20 0.33
METAP2 P50579 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4143531 1.00 PRKCA (0.33) PRKCAMMP12METAP2
SCHEMBL4145379 0.94
SCHEMBL4145376 0.94
Trifluoroacetic Acid SCHEMBL4153234 0.86 PRKCA (0.39) PRKCAMMP12
Trifluoroacetic Acid SCHEMBL4153237 0.86 PRKCA (0.39) PRKCAMMP12
SCHEMBL2156818 0.75 PRKCA (0.32) PRKCAMMP12
SCHEMBL4140597 0.74 PRKCA (0.40) PRKCAMMP12
SCHEMBL4152405 0.74 PRKCA (0.40) PRKCAMMP12
SCHEMBL4152401 0.74 PRKCA (0.40) PRKCAMMP12
SCHEMBL4145902 0.74 PRKCA (0.40) PRKCAMMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090136449-A1 Tetracyclic Indole Derivatives as Antiviral Agents ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136449-A1 Tetracyclic Indole Derivatives as Antiviral Agents IDO1, IDO2, ZC3HAV1 PRKCA 4320/4885MMP12 3563/4885METAP2 2167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.